Evidence map›Paper›PMID 18160637›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention.

Qiu-Lan Ma, Bruce Teter, Oliver J Ubeda, Takashi Morihara, Dilsher Dhoot, Michael D Nyby, Michael L Tuck, Sally A Frautschy, Greg M Cole

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. LR11/SorLA and its role in cardiovascular disease.International journal of cardiology. Heart & vasculature · 2026
    Review
  4. Review
  5. Review
  6. Dietary L-Lysine Requirement of Coho Salmon (Animals : an open access journal from MDPI · 2023
    Article
  7. Article
  8. Lipids and Secretory Vesicle Exocytosis.Advances in neurobiology · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Role of SORL1 in Alzheimer's Disease.Molecular neurobiology · 2015
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Qiu-Lan MaDepartment of Medicine, University of California, Los Angeles, California 90095, USA.
Bruce Teter
Oliver J Ubeda
Takashi Morihara
Dilsher Dhoot
Michael D Nyby
Michael L Tuck
Sally A Frautschy
Greg M Cole
Geriatric Research Education and Clinical Center · USUniversity of California, Los Angeles · USVA Greater Los Angeles Healthcare System · US

Funding

UCLA ALZHEIMERS DISEASE RESEARCH CENTERP50AG016570 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BREDESEN, DALE E. · 1999 to 2014
$25.9M
NSAID Inhibition of Alzheimer Pathology: Role of DHAR01AG013741 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COLE, GREGORY M · 1998 to 2010
$2.2M
Human tau neurodegeneration in Alzheimer'sR01AG021975 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FRAUTSCHY, SALLY ANN · 2004 to 2008
$1.2M
Can Omega 3 fatty acids Slow Alzheimer Pathogensis?R01AT003008 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COLE, GREGORY M · 2005 to 2008
$1.1M
NCCIH NIH HHS AT3008NCCIH NIH HHS R01 AT003008NIA NIH HHS AG13471NIA NIH HHS P50 AG016570NIA NIH HHS R01 AG013741NIA NIH HHS R01 AG021975
6 · The paper itself

Abstract

Environmental and genetic factors, notably ApoE4, contribute to the etiology of late-onset Alzheimer's disease (LOAD). Reduced mRNA and protein for an apolipoprotein E (ApoE) receptor family member, SorLA (LR11) has been found in LOAD but not early-onset AD, suggesting that LR11 loss is not secondary to pathology. LR11 is a neuronal sorting protein that reduces amyloid precursor protein (APP) trafficking to secretases that generate beta-amyloid (Abeta). Genetic polymorphisms that reduce LR11 expression are associated with increased AD risk. However these polymorphisms account for only a fraction of cases with LR11 deficits, suggesting involvement of environmental factors. Because lipoprotein receptors are typically lipid-regulated, we postulated that LR11 is regulated by docosahexaenoic acid (DHA), an essential omega-3 fatty acid related to reduced AD risk and reduced Abeta accumulation. In this study, we report that DHA significantly increases LR11 in multiple systems, including primary rat neurons, aged non-Tg mice and an aged DHA-depleted APPsw AD mouse model. DHA also increased LR11 in a human neuronal line. In vivo elevation of LR11 was also observed with dietary fish oil in young rats with insulin resistance, a model for type II diabetes, another AD risk factor. These data argue that DHA induction of LR11 does not require DHA-depleting diets and is not age dependent. Because reduced LR11 is known to increase Abeta production and may be a significant genetic cause of LOAD, our results indicate that DHA increases in SorLA/LR11 levels may play an important role in preventing LOAD.

Indexed as

Age FactorsAlzheimer DiseaseAmyloid beta-Protein PrecursorAnalysis of VarianceAnimalsCell Line, TumorDisease Models, AnimalDocosahexaenoic AcidsEmbryo, MammalianFemaleGene Expression RegulationHumansMaleMembrane Transport ProteinsMiceMice, Inbred C57BLAmyloid beta-Protein PrecursorDocosahexaenoic AcidsMembrane Transport ProteinsNerve Tissue ProteinsReceptors, LDLSorl1 protein, mouse

Identifiers

PMID18160637
PMCPMC2628584
OpenAlexW2061632909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.